Search results
Walmart shares keep climbing as analysts digest blockbuster 1Q earnings By Proactive Investors
Investing.com· 8 hours agoWalmart shares keep climbing as analysts digest blockbuster 1Q earnings
Nvidia Falls As Rival Teams Up With Microsoft Amid AI Chip Shortage; Is It A Buy Now?
Investor's Business Daily· 6 hours agoThat helped Nvidia turn the tide on its results. It reported three quarters of declining...
Earnings call: Eyenovia reports Q1 2024 results, focuses on product pipeline By Investing.com
Investing.com· 1 day agoEyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company specializing in ophthalmic diseases,...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks· 2 days agoThe first-quarter earnings season has come to an end for large drug and biotech companies, with Bayer reporting its results earlier this week. Per the Zacks ...
Fox Corporation (NASDAQ:FOX) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoFox Corporation (NASDAQ:FOX) Q3 2024 Earnings Call Transcript May 8, 2024 Fox Corporation isn’t one...
Where Will Disney Stock Be in 1 Year?
Motley Fool via Yahoo Finance· 4 days agoManagement said it expects the third quarter to be "roughly comparable" to last year. Disney said it would invest $60 billion in parks over the next 10...
Down but Not Out: 3 Stocks to Buy on a Post-Earnings Dip
The Motley Fool via AOL· 6 days agoAs a result, legitimate bargains rarely last long. So make today the day you decide for yourself...
IMAX, MEGARAMA Expand Partnership for 3 New Locations in France
Zacks· 2 days agoFree Report) has signed a new deal with French exhibition company, MEGARAMA, to bring three new state-of-the-art IMAX with Laser systems across France. One of the new IMAX ...
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 2 days agoFurther, Lilly entered into a collaboration with Verve Therapeutics to test three potential...
Ionis, Biogen Down on Ending Development of ALS Drug - Biogen (NASDAQ:BIIB), Heron Therapeutics...
Benzinga· 5 hours agoShares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market...
